CLSI C43-A2
Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E
standard by Clinical and Laboratory Standards Institute, 03/01/2010
CLSI EP28-A3cS (R2018)
Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, Third Edition, EP28A3E
standard by Clinical and Laboratory Standards Institute, 10/01/2010
CLSI C28P3
Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Proposed Guideline-Third Edition, C28-P3
standard by Clinical and Laboratory Standards Institute, 04/01/2008
CLSI QMS19
Customer Focus in a Quality Management System, 1st Edition, QMS19Ed1E
standard by Clinical and Laboratory Standards Institute, 09/01/2017
CLSI QMS14-A (R2018)
Quality Management System: Leadership and Management Roles and Responsibilities; Approved Guideling, QMS14AE
standard by Clinical and Laboratory Standards Institute, 12/01/2012
CLSI MM05-A2 (R2018)
Nucleic Acid Amplification Assays for Molecular Hematopathology; Approved Guideline-Second Edition,MM05A2E
standard by Clinical and Laboratory Standards Institute, 03/01/2012
CLSI M44-A2
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, 3rd Edition, M44Ed3E
standard by Clinical and Laboratory Standards Institute, 12/10/2018
CLSI POCT01-A2
Point-of-Care Connectivity; Approved Standard, POCT01A2E
standard by Clinical and Laboratory Standards Institute, 07/28/2006
CLSI M53-A
Criteria for Laboratory Testing and Diagnosis of Human Immunodeficiency Virus Infection; Approved Guideline, M53A
standard by Clinical and Laboratory Standards Institute, 06/01/2011